1 year return (CAGR)
-11.03%
Tscan Therapeutics Inc Exchange (NASDAQ, USD)
TCRX
0.32
-0.04 (-3.20%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-16.39%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
67.55M
Price/Sales
6.54
Ent value
20.81M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.26 |
| Daily high | 1.29 |
| Daily low | 1.16 |
| Daily Volume | 802K |
| All-time high | 13.48 |
| 1y analyst estimate | 6.00 |
| Beta | 1.07 |
| EPS (TTM) | -0.91 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 11 Mar 2026 |
Downside potential
Loading...
Downside potential data
| TCRX | S&P500 | |
| Current price drop from All-time high | -97.62% | -2.63% |
| Highest price drop | -93.36% | -56.47% |
| Date of highest drop | 19 Dec 2025 | 9 Mar 2009 |
| Avg drop from high | -71.45% | -10.69% |
| Avg time to new high | 151 days | 12 days |
| Max time to new high | 1185 days | 1805 days |
News
